Divi's Laboratories

DIVISLAB

₹ 3,793.50

₹ 3.55

0.09%

Divi's Laboratories
Market Sentiment

Timeline	Returns	Volume
Daily	-	-
Weekly	-3.99%	12,19,427
Monthly	1.45%	91,83,349

Divi's Laboratories
Performance

DATA

CHART

Timeline	Daily	Weekly	Monthly
DIVISLAB	-	-3.99%	1.45%
Index	-	-1.46%	-2.67%
Peer Avg.	-	-3.09%	-0.56%

*Avg of index constituents

Divi's Laboratories
Fundamentals

DATA

CHART

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
DIVISLAB	39.57	9.98	21.92	28.15	35.08	0.90
Index	36.20	6.77	17.25	17.89	19.69	1.20
Peer Avg.	40.04	4.96	12.35	14.74	18.51	0.87

*Avg of index constituents

Divi's Laboratories
Key Metrics

DATA

CHART

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	29.59%	50.02%	28.15	35.08
FY '20-21	28.61%	43.27%	23.73	31.86
FY '19-20	8.95%	2.38%	19.25	25.29

Divi's Laboratories
Shareholding Pattern

Promoters : 51.94%

FII : 18.45%

DII : 18.32%

Public : 11.28%

Others : 0.01%

Divi's Laboratories
Profit & Loss

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	8,919.83	5,041.89	3,992.91	2,954.49
FY '20-21	6,884.01	4,043.03	2,904.03	1,969.51
FY '19-20	5,352.49	3,532.68	2,009.56	1,374.62

All values are in crores

Divi's Laboratories
Peer Comparison

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
DIVISLAB	8,919.83	5,041.89	3,992.91	2,954.49
SHREECEM	14,657.72	10,982.50	4,219.50	2,356.61
DLF	4,885.47	3,104.51	2,292.92	1,089.49

All values are in crores

Divi's Laboratories
Similar Stocks

Glaxosmithkline Pharmaceuticals

GLAXO

₹ 1,972.30

- ₹ 3.60

-0.18%

Divi's Laboratories Share Price

Divi's Laboratories Limited is an Indian company that manufactures and markets active ingredients (APIs), intermediates and nutrients for export. The company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to its generic business, the Company supports pharmaceutical companies through custom synthesis businesses in the commercialization of their proprietary products, from gram-scale requirements for clinical trials to launch and late life cycle management. The company's subsidiaries are Divis Laboratories (USA) Inc and Divi's Laboratories Europe AG.

Divi's Laboratories FAQs

How to Buy Divi's Laboratories Share?

To purchase Divi's Laboratories shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Divi's Laboratories (ticker symbol: divislab) on the trading platform provided by your broker and purchase the shares.

What's Divi's Laboratories share price today?

The stock price of Divi's Laboratories as of 10 May 2024 is ₹3,793.50

What is the Market Cap of Divi's Laboratories?

Market capitalisation represents the total market value of a company's outstanding shares. As of 10 May 2024, Divi's Laboratories (ticker symbol: divislab) has a market capitalisation of approximately ₹8,89,82,41,33,302.00

What is the PE and PB ratio of Divi's Laboratories?

Divi's Laboratories Ltd's price-to-book ratio as of 10 May 2024 is 9.983163, reflecting the market's valuation compared to its asset value. As of 10 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 39.567066, indicating the market values the company at around ₹39.57 for every ₹1 of earnings

What is the 52 Week High and Low of Divi's Laboratories Share?

Divi's Laboratories Ltd (divislab) hit its 52-week high at ₹4,100.00, and its 52-week low at { ₹3,051.00}.